Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer's and other dementias.
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer's and other dementias.
<iframe src="https://statesidedaily.com/embed/cluster/8bf9d8dd1e27e5639c43527d766f6e9396d516af" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait"></iframe>
